Seattle Genetics Total Assets 2006-2019 | SGEN

Seattle Genetics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Seattle Genetics total assets for the quarter ending September 30, 2019 were $2.098B, a 33.78% increase year-over-year.
  • Seattle Genetics total assets for 2018 were $1.503B, a 71.23% increase from 2017.
  • Seattle Genetics total assets for 2017 were $0.878B, a 4.72% increase from 2016.
  • Seattle Genetics total assets for 2016 were $0.838B, a 6.33% decline from 2015.
Seattle Genetics Annual Total Assets
(Millions of US $)
2018 $1,503
2017 $878
2016 $838
2015 $895
2014 $459
2013 $484
2012 $471
2011 $425
2010 $330
2009 $388
2008 $188
2007 $149
2006 $98
2005 $90
Seattle Genetics Quarterly Total Assets
(Millions of US $)
Q3 2019 $2,098
Q2 2019 $1,568
Q1 2019 $1,593
Q4 2018 $1,503
Q3 2018 $1,568
Q2 2018 $1,581
Q1 2018 $1,474
Q4 2017 $878
Q3 2017 $853
Q2 2017 $757
Q1 2017 $784
Q4 2016 $838
Q3 2016 $850
Q2 2016 $863
Q1 2016 $879
Q4 2015 $895
Q3 2015 $907
Q2 2015 $408
Q1 2015 $446
Q4 2014 $459
Q3 2014 $478
Q2 2014 $470
Q1 2014 $476
Q4 2013 $484
Q3 2013 $478
Q2 2013 $467
Q1 2013 $466
Q4 2012 $471
Q3 2012 $415
Q2 2012 $420
Q1 2012 $413
Q4 2011 $425
Q3 2011 $420
Q2 2011 $454
Q1 2011 $481
Q4 2010 $330
Q3 2010 $349
Q2 2010 $358
Q1 2010 $368
Q4 2009 $388
Q3 2009 $326
Q2 2009 $213
Q1 2009 $221
Q4 2008 $188
Q3 2008 $214
Q2 2008 $226
Q1 2008 $237
Q4 2007 $149
Q3 2007 $141
Q2 2007 $149
Q1 2007 $155
Q4 2006 $98
Q3 2006 $107
Q2 2006 $116
Q1 2006 $81
Q4 2005 $90
Q3 2005 $98
Q2 2005 $107
Q1 2005 $112
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $18.451B $0.655B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.901B 16.46
CSL (CSLLY) Australia $94.668B 0.00
Gilead Sciences (GILD) United States $79.957B 9.91
Vertex Pharmaceuticals (VRTX) United States $60.559B 61.81
Biogen (BIIB) United States $51.632B 8.86
Illumina (ILMN) United States $47.916B 52.57
Regeneron Pharmaceuticals (REGN) United States $42.333B 18.54
Alexion Pharmaceuticals (ALXN) United States $24.897B 12.30
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.365B 40.31
BioMarin Pharmaceutical (BMRN) United States $16.010B 0.00
Genmab (GNMSF) Denmark $14.044B 62.03
Alnylam Pharmaceuticals (ALNY) United States $13.305B 0.00
Galapagos (GLPG) Belgium $12.398B 31.94
Exact Sciences (EXAS) United States $11.656B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.384B 54.64
BeiGene (BGNE) Cayman Islands $10.251B 0.00
Sarepta Therapeutics (SRPT) United States $9.713B 0.00
Bio-Techne Corp (TECH) United States $8.362B 55.97
Guardant Health (GH) United States $7.827B 0.00
QIAGEN (QGEN) Netherlands $7.710B 25.14
BioNTech SE (BNTX) Germany $7.297B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.172B 18.23
Amarin (AMRN) Ireland $7.166B 0.00
Moderna (MRNA) United States $7.002B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.863B 0.00
Reata Pharmaceuticals (RETA) United States $6.547B 0.00
Exelixis (EXEL) United States $6.211B 17.47
Ascendis Pharma (ASND) Denmark $5.919B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.718B 0.00
Bluebird Bio (BLUE) United States $5.393B 0.00
Repligen (RGEN) United States $5.201B 94.25
China Biologic Products (CBPO) China $4.606B 25.94
MorphoSys AG (MOR) Germany $4.252B 0.00
Blueprint Medicines (BPMC) United States $3.983B 0.00
Mirati Therapeutics (MRTX) United States $3.842B 0.00
Immunomedics (IMMU) United States $3.741B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.609B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.517B 0.00
MyoKardia (MYOK) United States $3.475B 0.00
NeoGenomics (NEO) United States $3.404B 181.11
Adaptive Biotechnologies (ADPT) United States $3.403B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.292B 0.00
Alkermes (ALKS) Ireland $3.149B 0.00
Zai Lab (ZLAB) China $3.002B 0.00
Acceleron Pharma (XLRN) United States $2.986B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.978B 0.00
Halozyme Therapeutics (HALO) United States $2.950B 0.00
Genmab (GMAB) Denmark $2.938B 6.05
UniQure (QURE) Netherlands $2.907B 0.00
Emergent Biosolutions (EBS) United States $2.893B 28.74
Amicus Therapeutics (FOLD) United States $2.691B 0.00
Epizyme (EPZM) United States $2.326B 0.00
Arena Pharmaceuticals (ARNA) United States $2.319B 5.39
RA PHARMCTL INC (RARX) United States $2.217B 0.00
Myriad Genetics (MYGN) United States $2.151B 31.78
Denali Therapeutics (DNLI) United States $2.123B 0.00
Insmed (INSM) United States $2.027B 0.00
Principia Biopharma (PRNB) United States $1.879B 0.00
Fate Therapeutics (FATE) United States $1.837B 0.00
REGENXBIO (RGNX) United States $1.807B 0.00
Zymeworks (ZYME) Canada $1.737B 0.00
Arvinas (ARVN) United States $1.731B 0.00
Akcea Therapeutics (AKCA) United States $1.670B 0.00
Editas Medicine (EDIT) United States $1.643B 0.00
Ligand Pharmaceuticals (LGND) United States $1.625B 31.26
Intra-Cellular Therapies (ITCI) United States $1.476B 0.00
Innoviva (INVA) United States $1.470B 4.33
Dicerna Pharmaceuticals (DRNA) United States $1.449B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.424B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.409B 0.00
Coherus BioSciences (CHRS) United States $1.393B 0.00
Alector (ALEC) United States $1.371B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.197B 0.00
DBV Technologies S.A (DBVT) France $1.164B 0.00
Zealand Pharma (ZEAL) Denmark $1.149B 0.00
Codexis (CDXS) United States $1.087B 0.00
Sangamo Therapeutics (SGMO) United States $1.025B 0.00
Revance Therapeutics (RVNC) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.902B 0.00
Heska (HSKA) United States $0.833B 212.78
Mesoblast (MESO) Australia $0.829B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.825B 6.94
Cellectis S.A (CLLS) France $0.783B 0.00
Vericel (VCEL) United States $0.779B 290.50
GENFIT S.A (GNFT) France $0.777B 0.00
Twist Bioscience (TWST) United States $0.765B 0.00
Adverum Biotechnologies (ADVM) United States $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.745B 0.00
Intellia Therapeutics (NTLA) United States $0.741B 0.00
ANI Pharmaceuticals (ANIP) United States $0.739B 12.61
Sorrento Therapeutics (SRNE) United States $0.727B 0.00
NantKwest (NK) United States $0.726B 0.00
UROGEN PHARMA (URGN) United States $0.723B 0.00
Retrophin (RTRX) United States $0.717B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Cara Therapeutics (CARA) United States $0.676B 0.00
Anika Therapeutics (ANIK) United States $0.672B 21.81
AC Immune SA (ACIU) Switzerland $0.656B 15.17
Prothena (PRTA) Ireland $0.614B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.581B 0.00
Precision BioSciences (DTIL) United States $0.563B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.541B 0.00
Agenus (AGEN) United States $0.529B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Dynavax Technologies (DVAX) United States $0.517B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.516B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.509B 0.00
Arcus Biosciences (RCUS) United States $0.480B 0.00
Bellus Health (BLU) Canada $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.451B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.451B 3.12
AnaptysBio (ANAB) United States $0.438B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.415B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
Pfenex (PFNX) United States $0.397B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
Cue Biopharma (CUE) United States $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
PDL BioPharma (PDLI) United States $0.375B 9.37
Avid Bioservices (CDMO) United States $0.368B 0.00
Mersana Therapeutics (MRSN) United States $0.364B 0.00
Cel-Sci (CVM) United States $0.353B 0.00
Stemline Therapeutics (STML) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Puma Biotechnology (PBYI) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Cellular Biomedicine (CBMG) United States $0.340B 0.00
Inovio Pharmaceuticals (INO) United States $0.340B 0.00
Albireo Pharma (ALBO) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
VBI Vaccines (VBIV) United States $0.317B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
Compugen (CGEN) Israel $0.312B 0.00
Geron (GERN) United States $0.290B 0.00
OSMOTICA PHARM (OSMT) United States $0.289B 0.00
IVERIC Bio (ISEE) United States $0.279B 0.00
WAVE Life Sciences (WVE) Singapore $0.278B 0.00
Sutro Biopharma (STRO) United States $0.275B 0.00
ADMA Biologics Inc (ADMA) United States $0.272B 0.00
ChromaDex (CDXC) United States $0.266B 0.00
Kamada (KMDA) Israel $0.262B 7.65
Prometic Life Sciences (LMNL) Canada $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Seres Therapeutics (MCRB) United States $0.244B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Theratechnologies (THTX) Canada $0.225B 0.00
Cerecor (CERC) United States $0.224B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.223B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.217B 0.00
Exicure (XCUR) United States $0.213B 0.00
XOMA (XOMA) United States $0.209B 0.00
Athersys (ATHX) United States $0.201B 0.00
Fortress Biotech (FBIO) United States $0.199B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.189B 0.00
Five Prime Therapeutics (FPRX) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.187B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.185B 0.00
Alcobra (ARCT) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.184B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.173B 0.00
TELA Bio (TELA) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Palatin Technologies (PTN) United States $0.167B 4.56
Menlo Therapeutics (MNLO) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Novavax (NVAX) United States $0.154B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
Applied Genetic Technologies (AGTC) United States $0.148B 0.00
Verastem (VSTM) United States $0.146B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 3.65
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Arsanis (XFOR) United States $0.128B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.126B 0.00
BioTime (LCTX) United States $0.125B 6.43
Aptinyx (APTX) United States $0.121B 0.00
VTv Therapeutics (VTVT) United States $0.119B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
OvaScience (MLND) United States $0.111B 0.00
Clearside Biomedical (CLSD) United States $0.110B 0.00
Antibe Therapeutics (ATBPF) Canada $0.109B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.105B 0.00
Acorda Therapeutics (ACOR) United States $0.103B 0.00
Synlogic (SYBX) United States $0.103B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
Emmaus Life Sciences (EMMA) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Trevena (TRVN) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.081B 5.23
Vaccinex (VCNX) United States $0.075B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
Idera Pharmaceuticals (IDRA) United States $0.057B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Evogene (EVGN) Israel $0.044B 0.00
Soligenix (SNGX) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
BioCardia (BCDA) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Unum Therapeutics (UMRX) United States $0.030B 0.00
Novogen (KZIA) Australia $0.029B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Advaxis (ADXS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
IBio (IBIO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.005B 0.00